SCHEMBL4306068

SCHEMBL4306068

CN(C)c1ccc(C(N)=S)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
ADRA2A P08913 2/20 0.36
ADRA2B P18089 2/20 0.36
ADRA2C P18825 2/20 0.36
HPGD P15428 2/20 0.36
RAD52 P43351 1/20 0.36
ALOX15 P16050 2/20 0.36
TSHR P16473 2/20 0.36
MAOA P21397 2/20 0.36
HSD17B10 Q99714 1/20 0.36
NOS1 P29475 1/20 0.35
KCNH2 Q12809 2/20 0.35
MAT2A P31153 1/20 0.35
TP53 P04637 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4301391 0.79 ALDH1A1 (0.43) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL4303343 0.78 ALDH1A1 (0.42) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL4302622 0.78 ALDH1A1 (0.42) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL4301401 0.77 AR (0.40) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL23389221 0.76 RXRA (0.49) ALDH1A1MAPTKMT2ASMN1; SMN2HPGD
SCHEMBL4302585 0.75 PSMB5 (0.41) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL4301042 0.75 ALDH1A1 (0.67) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL6843558 0.75 ALDH1A1 (0.39) ALDH1A1MAPTGAAHPGDRAD52
SCHEMBL4296223 0.75 GAA (0.37) ALDH1A1MAPTKMT2ASMN1; SMN2GAA
SCHEMBL19454401 0.74 KMT2A (0.42) ALDH1A1MAPTKMT2ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
WO-2009120826-A1 2-ARYL- AND 2-HETEROARYLTHIAZOLYL COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF WYETH (US) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B ALDH1A1 2705/4885MAPT 2418/4885KMT2A 3676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.